Therefore, an RNA-based study capable of sensitively detecting ETV6::ABL1 should be used for diagnostic evaluation, especially in patients with MPN featuring eosinophilia and lacking the BCR::ABL1, considering clonal burden and disease phenotype in the interpretation of results. The gene discussed is BCR; the disease is myeloproliferative neoplasm.